MAPS Medical Affairs Textbook Featured

The MAPS Medical Affairs Textbook

Medical Affairs is one of the three strategic pillars of the pharmaceutical and MedTech industries, but while clear career paths exist for Commercial and Research & Development, there is no formal training structure for Medical Affairs professionals. Medical and scientific expertise is a prerequisite for entry into the function, and many people transitioning into Medical Affairs have advanced degrees such as PhD, MD, or PharmD. However, these clinical/scientific experts may not be especially well-versed in aspects of industry such as the drug development lifecycle, crossfunctional collaborations within industry, and digital tools that are transforming the ways Medical Affairs generates and disseminates knowledge. The MAPS Medical Affairs Textbook is both a primer for aspiring and early-career Medical Affairs professionals as well as a broad overview of Medical Affairs for those seeking to power a crossfunctional Medical Affairs career. This first-of-its-kind resource equips readers with the baseline skills and understanding to excel across Medical Affairs roles.

MAPS Medical Affairs Textbook Cover

Features:

  • Defines the purpose and value of Medical Affairs and provides clear career paths for scientific experts seeking their place within the pharmaceutical and MedTech industries.
  • Provides guideance and baseline competencies for roles within Medical Affairs including Medical Communications, Evidence Generation, Field Medical, Compliance, and many others.
  • Specifies the “true north” of the Medical Affairs profession as ensuring patients receive maximum benefit from industry innovations including drugs, diagnostics and devices.
  • Presents the purpose and specific roles of Medical Affairs roles across organization types including biotechs, small/medium/large pharma and device/diagnostic companies, taking into account adjustments in the practice of Medical Affairs to meet the needs of developing fields.
  • Leverages the expertise of over 80 Medical Affairs leaders across companies, representing the first unified, global understanding of the Medical Affairs profession.

Contributors

(Affiliations at time of publication)

Mónica de Abadal, SVP, Head of Medical Affairs, North America, Ipsen

Bill Altonaga, VP, Global Medical Safety and Governance, Becton Dickinson

Jim Alexander, CEO and Founder, Industry Pharmacists Organization

Rachele Berria, VP and Head of Medical, US Biopharmaceuticals, AstraZeneca

Idal Beer, VP Medical and Scientific Affairs, Medication Management Solutions, Becton Dickinson

George Betts, ED, Head of Medical Affairs Operations, Regeneron

Loubna Bouarfa, CEO and Founder, OKRA.ai

Isabelle Bocher-Pianka, Chief Patient Affairs Officer, Ipsen

Sokhon Bouy, Head of Area Medical Operations, Abbvie

Deb Braccia, Head of Global Medical Affairs Excellence, Kyowa Kirin

Kimberly Braithwaite, National Manager Medical Science Liaison, EMD Serono Canada

Søren Buur, Director, Head of Medical Affairs Operations, Lundbeck

Greg Christopherson, VP, Medical Affairs, Medline Industries

Sarah Clark, Head of Medical Affairs, Biogen Digital Health

Gail Cawkwell, Chief Medical Affairs Officer, Aclaris Therapeutics

Omar Dabbous, VP, Global Health Economics and Outcomes Research and Real World Evidence, AveXis

Joao Dias, Scientific Affairs Head, Haemonetics

Shontelle Dodson, EVP, Global Medical Affairs, Astellas

Maureen Doyle-Scharff, ED, Global Medical Grants, Pfizer

Victoria Elegant, VP, Medical, Asia Pacific and Global Lead, Access to Healthcare, Amgen

Ann Ford, Partner, Managing Director, HPS Advise

Wendy Fraser, ED, Field Medical Center of Excellence and Global Scientific Training, Merck

Monique Furlan, Global Field Based Medical Stakeholders Scientific Engagement Lead, Sanofi

Stacey Fung, Head, Global Medical Information, Gilead Sciences

Catrinel Galateanu, Head of Global Medical Affairs, UCB

Kathy Gann, Medical Affairs, MSL Professional

Arnaud Gatignol, Medical Operations Manager, bioMérieux

Suzanne Giordano, Head of Field Medical, Axsome Therapeutics

Suzana Giffin, VP, Global Medical and Scientific Affairs, Merck

Kristin Goettner, Sr. Director, Medical Information and Knowledge Integration, Janssen Scientific Affairs

Rebecca Goldstein, Senior Principal, Strategic Consulting, Envision

Oleks Gorbenko, Global Patient Affairs Director, Ipsen

Tricia Gooljarsingh, VP, Medical Affairs, Fulcrum Therapeutics

Andrew Greenspan, Chief Global Medical Affairs Officer, Janssen Pharmaceutical Companies, Johnson & Johnson

Ann Hartry, Associate VP, Value, Evidence and Outcomes, Neuroscience, Eli Lilly

Kristine Healey, Associate VP, COO, Medical Affairs Launch Readines, Eli Lilly

Meg Heim, President and Founder, Heim Global Consulting

Evelyn Hermes-DeSantis, Director, Research and Publications, phactMI; Professor Emerita, Rutgers, The State University of New Jersey

Klaus Hoerauf, VP, Global Medical and Scientific Affairs, Medication Delivery Solutions, Becton Dickinson

Noreen Hussain, Senior Medical Writer, MedComms Experts

Sandrine Jabouin, Account Director, MedComms Experts

Greta James-Chatgilaou, Director, Field Medical Strategy and Execution, Biogen Intercontinental Region

Renu Juneja, Head, Scientific Evidence and Communications, Oncology US Medical Affairs, Janssen

Tobi Karchmer, Chief Medical Officer, Baxter

Christopher Keenan, ED, External Engagement and Enablement, Global Medical, Bristol Myers Squibb

Richard Kemper, Global Medical Omnichannel Head, General Medicines, Sanofi

Dee Khuntia, Chief Medical Officer, Varian, A Siemens Healthineers Company

Karen King, EVP Scientific and Medical Services, Medical Communications, Open Health Scientific Communications

Joe Kohles, Senior Medical Strategy Consultant

Tamas Koncz, Medical Affairs Executive, NY

Charlotte Kremer, Medical Affairs Executive, Chief Medical Officer, MAPS

Bagrat Lalayan, ED, Global Medical Head, Women’s Cancer Care, Oncology, Eisai

Sean Lilienfeld, VP, Global Medical Affairs, Boston Scientific

Maureen Lloyd, Executive Director, LLOYDMJMC LLC

Deborah Long, SVP of Medical Affairs, Vertex Pharmaceuticals

David Macarios, VP, Global Health Economics and Outcomes Research and Real-World Evidence, Becton Dickinson

Robert Matheis, President and CEO, International Society for Medical Publication Professionals

Danny McBryan, Medical Affairs Executive

Siobhan Mitchell, Global Medical Office Head and Chief of Staff to SVP Medical Head, Sanofi

Mark Miller, Chief Medical Officer, bioMérieux

Hany Moselhi, SVP, Chief Medical Officer, Roche Diagnostics

Lori Mouser, Senior Director, Global Head of Scientific Engagement, Oncology Medical Affairs, Daiichi Sankyo

Ameet Nathwani, CEO, Dewpoint Therapeutics

Judith Nelissen, VP, Head Global Health Economics and Outcomes Research, Astellas

Liviu Niculescu, Chief Medical Affairs Officer, Innovative Medicines U.S., Novartis

Nikolai Nikolov, Medical Affairs Executive

Marie-Ange Noue, Sr. Director and Head of North America Scientific Communications, EMD Serono

Tam Nguyen, Deputy Director of Research, St. Vincent’s Hospital, Melbourne

Bjorn Oddens, SVP, Head of Global Medical and Scientific Affairs, Merck

Rishi Ohri, Head of Digital Excellence, Medical Affairs, Astellas

Kirtida Pandya, ED and Head, Medical Services and Operations, Sandoz

Jovanka Paunovich, Director, Strategic Portfolio Initiatives, US Medical Affairs, Oncology, Abbvie

Danie du Plessis, EVP, Medical Affairs, Kyowa Kirin

Peter Piliero, VP, Medical Affairs, Melinta Therapeutics

John Pracyk, Chief Medical Safety Officer, SVP, Medical and Scientific Affairs, Olympus

Charlotte Raabe-Hielscher, HRBP Lead, Established Markets Commercial, Astellas

Patrick Reilly, President, Reilly Consulting

Ross “Rusty” Segan, Chief Medical Officer (former), Medical and Scientific Affairs, Olympus

Jessica Santos, Global Compliance and Quality Director, DPO, Oracle Life Sciences

Holly Schachner, SVP of Clinical Development, Northsea Therapeutics

Roz Schneider, Head of Global Patient Affairs, BioMarin

Roslyn Schneider, VP, Head of Global Patient Affairs, BioMarin

Kirk Shepard, (former) CMO and SVP, Head of Global Medical Affairs, Oncology, Eisai

Sandra Silvestri, EVP and CMO, Ipsen Ronald Silverman, SVP, Chief Medical

Officer, 3M HealthCare

William Sigmund, EVP and Chief Medical Officer, Becton Dickinson

Darryl Sleep, SVP, Global Medical and Chief Medical Officer, Amgen

Garth Sundem, Director, Communications and Marketing, MAPS

Rich Swank, (former) Head of Field Medical, Amgen

Paul Tebbey, COO, Elusys Therapeutics

Ajay Tiku, Regional Medical Head, Innovative Medicines, Asia Pacific, Middle East and Africa (APMA), Novartis

Leonard Valentino, CEO, National Hemophilia Foundation

Marleen van der Voort, ED, Scientific Communications and Content, Astellas

Jill Voss, Head of Scientific Communications and Medical Information, Neuroscience Franchise, Novartis

Anna Walz, Founder, MedEvoke, CEO, Blue Highland Consulting

Stephanie Wei, Scientific Director and Team Lead, Alligent Group

Robin Winter-Sperry, President, Global Medical Affairs, Scientific Resilience Consulting